Nobilis therapeutics is pleased to report that the validation formalities for the European patent it has licensed from MassGeneral Brigham have now been completed in France, Germany, Greece, Italy, the Netherlands, Portugal and the United Kingdom. The patent that has already been issued in the US is titled “XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS”.
